Medeze all news related to

MEDEZE, Thailand’s Only Private Cell Bank, Receives GMDP PIC/S Certification for Investigational Cell Therapy Products from the Thai FDA

September 28, 2026

Medeze Group Public Company Limited (MEDEZE), Thailand’s only private cell bank certified under internationally aligned Thai standards, announced that its manufacturing facility has successfully passed an assessment by Thailand’s Food and Drug Administration (Thai FDA) in accordance with Good Manufacturing and Distribution Practice requirements under PIC/S guidelines.

MEDEZE Reinforces Its Leadership in Stem Cell Banking with Comprehensive Certifications

August 13, 2026

Including Ministry of Public Health Approval, Pharmaceutical Manufacturing License (Por.Yor.2), Cell Banking Accreditation, AABB, ISO, and Ongoing Research

MEDEZE, GPO build Thailand cell culture media production base

THURSDAY, JULY 09, 2026

MEDEZE, GPO and Cretan Associates will form GPO MEDEZE Empower with 105 million baht in registered capital to expand Thailand’s ATMPs and biopharma production.

Bio-banking boom puts Thailand on advanced healthcare map

THURSDAY, JUNE 25, 2026

Medeze Group is helping to position Thailand as a rising wellness deep-tech hub, linking bio-banking, cell therapy and medical tourism.

Thailand Makes History With Landmark Stem Cell Decree

WEDNESDAY, MAY 27, 2026

A new ministerial decree formally classifies stem cell and cell-based therapies as medicines under Thai law — ending years of regulatory ambiguity and opening a new chapter for advanced medical innovation in Southeast Asia

Medeze, Chula team up to strengthen Thailand’s biotech supply chain

TUESDAY, MAY 26, 2026

Medeze and Chulalongkorn University are developing recombinant protein production to strengthen Thailand’s biotech and ATMP industry.